Purpose: To characterize an asymptomatic carrier of ocular albinism without a known family history of visual impairment. Methods: Chart review of the patient’s medical records. Results: Genetic testing revealed a deletion of exon 3 in her GPR143 gene (LCA5 c.1273 deletion). Conclusions: The patient showed characteristics of heterozygous carrier status for GPR143 alterations, including linear pigmentary changes in the fundus. This case is notable for the absence of a known family history of visual impairment and may represent a sporadic GPR143 deletion. Further studies are needed to examine genetic variants and deletions with ocular albinism type 1.
van DorpDBErikssonAWDellemanJW, et al. Åland eye disease: no albino misrouting. Clin Genet. 1985;28:526-531. doi:10.1111/j.1399-0004.1985.tb00421.x
3.
SchiaffinoMVd’AddioMAlloniA, et al. Ocular albinism: evidence for a defect in an intracellular signal transduction system. Nat Genet. 1999;23(1):108-112. doi:10.1038/12715
4.
SamaraweeraPShenBNewtonJMBarshGSOrlowSJ.The mouse ocular albinism 1 gene product is an endolysosomal protein. Exp Eye Res. 2001;72(3):319-329. doi:10.1006/exer.2000.0962
5.
KruijtCCde WitGCBergenAAFlorijnRJSchalij-DelfosNEvan GenderenMM.The phenotypic spectrum of albinism. Ophthalmology. 2018;125(12):1953-1960. doi:10.1016/j.ophtha.2018.08.003
6.
LewisRA. Ocular albinism, X-linked. In: AdamMPFeldmanJMirzaaGM, et al., eds. GeneReviews®. University of Washington, Seattle; 2004:1993-2024.
7.
GarnerAJayBS.Macromelanosomes in X-linked ocular albinism. Histopathology. 1980;4:243-254. doi:10.1111/j.1365-2559.1980.tb02919.x
BaeKChoKKangSWKimSJKimJM.Peripheral reticular pigmentary degeneration and choroidal vascular insufficiency, studied by ultra wide-field fluorescein angiography. PLoS One. 2017;12(1):e0170526. doi:10.1371/journal.pone.0170526
17.
MayeurHRocheOVêtuC, et al. Eight previously unidentified mutations found in the OA1 ocular albinism gene. BMC Med Genet. 2006;7:41. doi:10.1186/1471-2350-7-41
